These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 7588088)

  • 1. Guidelines for the use of zidovudine in pregnant women with HIV infection.
    De Santis M; Noia G; Caruso A; Mancuso S
    Drugs; 1995 Jul; 50(1):43-7. PubMed ID: 7588088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.
    Connor EM; Sperling RS; Gelber R; Kiselev P; Scott G; O'Sullivan MJ; VanDyke R; Bey M; Shearer W; Jacobson RL
    N Engl J Med; 1994 Nov; 331(18):1173-80. PubMed ID: 7935654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV infection and zidovudine use in childbearing women.
    Sia J; Paul S; Martin RM; Cross H
    Pediatrics; 2004 Dec; 114(6):e707-12. PubMed ID: 15545619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of zidovudine use in HIV-infected pregnant women on vertical transmission of HIV in Mississippi.
    Palmer AL; Gay H; Currier MM
    J Miss State Med Assoc; 2000 Feb; 41(2):479-83. PubMed ID: 10710894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A risk-benefit assessment of zidovudine in the prevention of perinatal HIV transmission.
    Newell ML; Gibb DM
    Drug Saf; 1995 Apr; 12(4):274-82. PubMed ID: 7646826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial.
    ; de Vincenzi I
    Lancet Infect Dis; 2011 Mar; 11(3):171-80. PubMed ID: 21237718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors predictive of maternal-fetal transmission of HIV-1. Preliminary analysis of zidovudine given during pregnancy and/or delivery.
    Boyer PJ; Dillon M; Navaie M; Deveikis A; Keller M; O'Rourke S; Bryson YJ
    JAMA; 1994 Jun 22-29; 271(24):1925-30. PubMed ID: 7911164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zidovudine use to reduce perinatal HIV type 1 transmission in an urban medical center.
    Wiznia AA; Crane M; Lambert G; Sansary J; Harris A; Solomon L
    JAMA; 1996 May; 275(19):1504-6. PubMed ID: 8622226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current treatment strategies, complications and considerations for the use of HIV antiretroviral therapy during pregnancy.
    Senise JF; Castelo A; Martínez M
    AIDS Rev; 2011; 13(4):198-213. PubMed ID: 21975356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preventing perinatal HIV transmission: zidovudine use during pregnancy.
    Carmichael C
    Am Fam Physician; 1997 Jan; 55(1):171-4, 177-8. PubMed ID: 9012276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AIDS battle update: zidovudine okayed for pregnant women.
    RN; 1995 Jan; 58(1):67. PubMed ID: 7624707
    [No Abstract]   [Full Text] [Related]  

  • 12. Zidovudine for the reduction of perinatal transmission of human immunodeficiency virus.
    Yoder DK
    J Tenn Med Assoc; 1995 Jul; 88(7):272, 274. PubMed ID: 7658693
    [No Abstract]   [Full Text] [Related]  

  • 13. Ethical issues in studies in Thailand of the vertical transmission of HIV.
    Phanuphak P
    N Engl J Med; 1998 Mar; 338(12):834-5. PubMed ID: 9504948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zidovudine in pregnancy: is it dangerous for the fetus?
    Mandelbrot L; Guillonneau M; Jacqz-Aigrain E
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Jun; 9(2):209. PubMed ID: 7749803
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of antiretroviral therapy on pregnancy outcome in HIV-1 positive women.
    Kowalska A; Niemiec T; El Midaoui A; Burkacka E
    Med Wieku Rozwoj; 2003; 7(4 Pt 1):459-68. PubMed ID: 15010556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [HIV and pregnancy: risks of transmission and therapeutic possibilities].
    Ibe M; Knolle P; Beck T; Meyer zum Büschenfelde KH; Gerken G
    Gynakol Geburtshilfliche Rundsch; 1996; 36(4):188-93. PubMed ID: 9206551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ZDV reduces maternal transmission.
    AIDS Patient Care; 1994 Jun; 8(3):164. PubMed ID: 11362140
    [No Abstract]   [Full Text] [Related]  

  • 18. Genotypic resistance tests for the management of the HIV-infected pregnant woman.
    Bassetti D; Cargnel A
    Scand J Infect Dis Suppl; 2003; 106():70-4. PubMed ID: 15000589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. U.S. Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States.
    Mofenson LM;
    MMWR Recomm Rep; 2002 Nov; 51(RR-18):1-38; quiz CE1-4. PubMed ID: 12489844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Combined antiretroviral therapy for prevention of vertical HIV-1 transmission].
    Casas E; Gómez-Cano M; Adrados M; García-Lerma G; Calvo F; Soriano V
    An Med Interna; 1998 Mar; 15(3):148-51. PubMed ID: 9567423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.